{"schema_version":"secwatch.filing_event.v1","accession":"0001610853-26-000005","form_type":"8-K","ticker":"HSDT","cik":"0001610853","company_name":"Solana Co","filed_at":"2026-08-14T20:28:35+00:00","discovered_at":"2026-08-14T20:32:02.884331+00:00","generated_at":"2026-08-14T20:32:10.486045+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Solana Company Q2 2026: Revenue $2.5M, Net Loss $30.3M, PoNS Divested","bullets":["Revenue $2.5M (vs $43K prior year), staking revenue $2.5M; H1 2026 revenue $6.1M.","Net loss $30.3M ($0.38/share) vs $9.8M loss ($79.73/share) prior year; includes $6.8M severance from PoNS divestiture.","Completed divestiture of legacy PoNS medical device business; built first institutional validator cluster in Tokyo.","Raised $7.9M net in registered direct offering led by Mirae Asset; repurchased $2.3M shares (1.3M shares) in Q2.","G&A expenses $11.1M vs $3.3M prior year; operating loss $32.7M."],"urls":{"canonical":"https://secwatch.observer/filing/0001610853-26-000005","json":"https://secwatch.observer/filing/0001610853-26-000005.json","markdown":"https://secwatch.observer/filing/0001610853-26-000005.md","text":"https://secwatch.observer/filing/0001610853-26-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610853/000161085326000005/0001610853-26-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610853/000161085326000005/hsdt-20260814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-14T20:32:10.486045+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}